MRD Testing Is Becoming the Most Important Tool in Oncology Drug Development: Q&A with Eric Matthews
MRD testing is transforming oncology trials — compressing timelines, enriching populations, and generating earlier answers.
Eric Matthews
Advertisement
General manager of biopharma at Natera.
Articles by Eric Matthews
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies
2
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli
3
CSL Names Deborah Waterhouse as CEO and Manager Director
4
How MFN Deals May Impact Future Decisions
5